Article Text

News in brief

Statistics from

Schmallenberg vaccine licensed in France

Merial announced on August 9 that it has been granted a marketing authorisation under exceptional circumstances in France for its  SBVvax against Schmallenberg virus (SBV). The inactivated vaccine is indicated for active immunisation  to prevent viraemia due to SBV in sheep and cattle and is expected  to be available to veterinarians in France before …

View Full Text

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.